Zdrowie i gospodarka · 11/05/2023

FDA Clears Hydrochlorothiazide Oral Solution for Sale

The US Food and Drug Administration (FDA) has ruled that hydrochlorothiazide oral solution, 50mg/5mL, was not withdrawn from sale due to safety or effectiveness concerns, allowing it to remain on the market and enabling the FDA to approve new drug applications (ANDAs) that reference this product.